Skip to navigation Skip to content

Patriot News Organization

patriotnewsorganization.com

Primary Menu
  • Health News
  • Home
  • pe
FDA Approves First Therapy for Rare Pediatric Immune Disorder
Health News

FDA Approves First Therapy for Rare Pediatric Immune Disorder

10/23/2021

The US Food and Drug Administration has approved the regenerative tissue-based therapy Rethymic for patients with congenital athymia, a rare pediatric immune disorder where the thymus does not develop in utero. This is the first FDA-approved treatment for children born…

Read More
A Major Change? 6-Monthly Leuprolide for Central Precocious Puberty
Health News

A Major Change? 6-Monthly Leuprolide for Central Precocious Puberty

06/03/2021

The 6-month subcutaneously injectable leuprolide acetate (Fensolvi, Tolmar Pharmaceuticals) effectively and safely treats children with central precocious (early) puberty, research suggests. Findings from a 2-year phase 3 study of subcutaneous leuprolide acetate in 62 children with central precocious puberty were…

Read More
Recent Posts
  • Special requirements for cleaning medical center windows
  • How to calculate a moving budget
  • UKHSA and ONS publish latest Winter CIS data
  • Exploring artificial general intelligence for radiation oncology
  • New study sheds light on the connection between the microbiome and kidney stones
Copyright © All rights reserved. 2025 Patriot News Organization.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok